2017 American Transplant Congress
Third Liver Transplantation, Outcomes, and the Impact of Previous Graft Survival.
Introduction: Retransplantation with a third liver allograft is controversial with significant technical and medical challenges. National outcomes have not been described. We hypothesize that prior…2016 American Transplant Congress
Intra-Operative Hepatic Arterial Flow Predicts Hepatic Artery Complications After Deceased Donor Liver Transplantation.
Baylor University, Dallas, TX.
IntroductionHepatic arterial flow (HAF) is important for post liver transplant outcomes. This study was conducted to determine the predictive value of measured intraoperative HAF on…2016 American Transplant Congress
Caval Replacement versus Piggyback Liver Transplantation: The Toronto Experience.
General Surgery, Multi-Organ Transplant, University of Toronto, Toronto, ON, Canada.
Background:Caval replacement (CR) and piggyback (PB) techniques for deceased donor liver transplantation (DDLT) each have inherent advantages and disadvantages with no consensus on the optimal…2016 American Transplant Congress
Donor Transmited Rabies Outbreak Involving Four Transplant Recepients in Kuwait and Saudi Arabia.
Background and Aims: There have been 10 outbreaks of rabies following solid organ or corneal transplantation. In December 2014, 4 organ recipients died in 2…2016 American Transplant Congress
Growth of Liver Allografts in Pediatric Transplant Recipients.
Columbia University Medical Center, New York, NY.
IntroductionThe liver's capacity to grow in response to metabolic need is well known. However, the long-term growth of liver allografts transplanted in pediatric patients has…2016 American Transplant Congress
Time Course of Hepatic Graft Function Improvement After Ledipasivir/Sofosbuvir Treatment in Liver Transplant Recipients with HCV and Fibrosis or Cirrhosis Who Achieved SVR.
Background: In SOLAR-1, liver transplant recipients with HCV and either fibrosis or cirrhosis were treated at baseline with ledipasvir/sofosbuvir and ribavirin for 12 or 24…2016 American Transplant Congress
Assessing the Impact of the Share35 Liver Allocation Policy: Survival Outcomes Among Liver Re-Transplant Recipients.
Liver retransplantation (reLTx) is the only treatment option for those who experienced graft loss after primary liver transplantation (LTx). Yet, in an era of increasing…2016 American Transplant Congress
The Role of B Cells in Liver Transplant Tolerance.
Scarcely one would argue that donor-specific B cells and antibodies contribute to rejection of transplants. However, studies published in the past few years have provided…2016 American Transplant Congress
Durable Clinical and Immunologic Advantage of Living Donor Liver Transplantation (LDLT) in Children.
1Columbia University Medical Center, New York, NY; 2Weill Cornell Medical College, New York, NY.
Purpose:Despite good results, only 10% of liver transplants in children in the US are from living donors. In addition to optimal timing and graft quality,…2016 American Transplant Congress
Occult Multifocal Hepatocellular Carcinoma in Surgical Patients.
Introduction: Resection of hepatocellular carcinoma (HCC) is associated with high rates of intrahepatic recurrence. However, it is unclear whether recurrence results from occult multifocal disease…
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- 20
- Next Page »